 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 07/06/2026 |
$21.78 |
$22.20 |
$21.24 |
$22.08 |
1.57M | | 07/07/2026 |
$22.38 |
$23.47 |
$22.04 |
$23.24 |
2.29M | | 07/08/2026 |
$22.98 |
$25.24 |
$22.95 |
$24.56 |
4.02M | | 07/09/2026 |
$24.78 |
$25.17 |
$24.32 |
$24.84 |
1.44M | | 07/10/2026 |
$24.79 |
$24.79 |
$23.01 |
$23.61 |
2.10M |
 |
| Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing pipeline of cancer therapies. Its product candidates include revumenib, and axatilimab. It is developing revumenib, a potent, selective, small molecule inhibitor of the menin-MLL binding interaction for the treatment of KMT2A rearranged also known as mixed lineage leukemia rearranged, acute leukemias including acute lymphoblastic leukemia and acute myeloid leukemia (AML), and necleophosmin 1, also known as NPM1, mutant A. It is also exploring the use of revumenib as a treatment in solid tumors, specifically its activity in metastatic colorectal cancer. | |
 |

Syndax Pharmaceuticals (SNDX) has the following price history information. Looking back at SNDX historical stock prices for the last five trading days, on July 06, 2026, SNDX opened at $21.78, traded as high as $22.20 and as low as $21.24, and closed at $22.08. Trading volume was a total of 1.57M shares. On July 07, 2026, SNDX opened at $22.38, traded as high as $23.47 and as low as $22.04, and closed at $23.24. Trading volume was a total of 2.29M shares. On July 08, 2026, SNDX opened at $22.98, traded as high as $25.24 and as low as $22.95, and closed at $24.56. Trading volume was a total of 4.02M shares. On July 09, 2026, SNDX opened at $24.78, traded as high as $25.17 and as low as $24.32, and closed at $24.84. Trading volume was a total of 1.44M shares. On July 10, 2026, SNDX opened at $24.79, traded as high as $24.79 and as low as $23.01, and closed at $23.61. Trading volume was a total of 2.10M shares.
SNDX Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Syndax Pharmaceuticals shares, starting with a $10,000 purchase of SNDX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
07/12/2016 |
|
| End date: |
07/10/2026 |
|
| Start price/share: |
$11.40 |
|
| End price/share: |
$23.61 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
107.11% |
|
| Average Annual Total Return: |
7.55% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$20,706.38 |
|
| Years: |
10.00 |
|
|
 |
| Date |
Close |
| 07/06/2026 | $22.08 | | 07/07/2026 | $23.24 | | 07/08/2026 | $24.56 | | 07/09/2026 | $24.84 | | 07/10/2026 | $23.61 |
|
 |